Krystal Biotech Inc (KRYS)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 296,569 | 55,764 | 498 | — | — |
| Total assets | US$ in thousands | 1,055,840 | 818,355 | 558,450 | 626,295 | 310,844 |
| Total asset turnover | 0.28 | 0.07 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $296,569K ÷ $1,055,840K
= 0.28
Krystal Biotech Inc's total asset turnover ratio experienced a significant improvement over the years, as indicated by the data provided. The ratio was stagnant at 0.00 in the years 2020 and 2021. By December 31, 2022, the total asset turnover ratio remained low at 0.00. However, a positive trend emerged in the subsequent years, with the ratio increasing to 0.07 by December 31, 2023, and further improving to 0.28 by December 31, 2024.
This enhancement in total asset turnover suggests that Krystal Biotech Inc became more efficient in generating revenue relative to its total assets, reflecting improved asset utilization. The upward trend indicates that the company may have optimized its operations and asset management strategies, leading to higher revenue generation from its asset base. Such an increase in total asset turnover is generally viewed positively, as it signifies better efficiency and utilization of resources to drive revenue growth.
Peer comparison
Dec 31, 2024